10 Best Growth Stocks to Buy According to Billionaires

7. Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)

3-Years Sales Growth: 38.61%

Number of Hedge Fund Holders: 49

Number of Billionaires: 9

Value of Billionaire Holdings: $416,804,245

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) is another biopharmaceutical company that ranks as one of the best growth stocks to buy according to billionaires. It is a commercial-stage company that focuses on the development of commercialized therapies based on RNA interference. The company has developed several FDA-approved therapies including Amvuttra, Onpattro, Givlaari, and more.

On April 9, Joseph Stringer from Needham maintained a Buy rating on the stock, with a price target of $320. The analyst likes the strategic market position of the company, which has been boosted by the recent approval of Amvuttra to treat ATTR-CM. Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) had a successful 2024, with net product revenue exceeding $1.6 billion and an operating income of $95 million. Management noted that it remains a leader in TTR and that Vutrisiran has the potential to become standard care for ATTR cardiomyopathy. The TTR franchise reported a revenue growth of 35% during the fiscal fourth quarter of 2024.